Ayush Pharmaceuticals and Marketing Division

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNSAFE ADD1 refused line

  Food additive unsafe under section 409

  The product appeared to contain a food additive that is unsafe within the meaning of section 409 of the FD&C Act, the section that governs which food additives may be used and under what conditions.

Questions about Ayush Pharmaceuticals and Marketing Division

Is Ayush Pharmaceuticals and Marketing Division on an FDA import alert?

Yes. As of October 27, 2026, Ayush Pharmaceuticals and Marketing Division is on the red list of FDA Import Alert 99-45, “Foods that are or contain an unsafe food additive”, for amla plex enhanced chavanprash; FDA published the listing on June 23, 2023.

Has FDA refused shipments from Ayush Pharmaceuticals and Marketing Division?

Yes. FDA refused 1 shipment line from Ayush Pharmaceuticals and Marketing Division on May 16, 2023. The most recent, on May 16, 2023, was herbals & botanicals (not teas), n.e.c., charged as UNSAFE ADD (food additive unsafe under section 409).

Why did FDA refuse Ayush Pharmaceuticals and Marketing Division's shipments?

The most frequent charges are NUTRIT LBL (nutrition information missing from label, 1 line) and UNSAFE ADD (food additive unsafe under section 409, 1 line).

What is Ayush Pharmaceuticals and Marketing Division's FEI number?

Ayush Pharmaceuticals and Marketing Division's FDA Establishment Identifier (FEI) is 3015429584.

Can shipments from Ayush Pharmaceuticals and Marketing Division still enter the U.S.?

Shipments of amla plex enhanced chavanprash from Ayush Pharmaceuticals and Marketing Division can be detained without physical examination under Import Alert 99-45; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).